Guerbet Worldwide
Asia Pacific
Belgium
Brazil
France
Germany
Italy
Japan
Korea
Mexico
Turkey
United Kingdom
USA
MEDEX
SIMAFEX
Cours de l'action
97.40 €
English
/
Français
Our Group
Patients
Our products
R&D Innovation
Investors
Careers
Investors
Guerbet in brief
Corporate governance
Diary
General meetings
Documents
The Guerbet Share
Regulated information
Stay informed
Home
>
Investors
>
Documents
Documents
Presentations
Reports
2012
2012 Results & outlook March 2013
First half results & outlook July 2012
Registration document
First half report
2011
2011 Results & outlook March 2012
First half results & outlook July 2011
Registration document
First half report
2010
2010 Results & outlook March 2011
First half results & outlook July 2010
Registration document
First half report
2009
2009 Results & outlook March 2010
First half results & outlook July 2009
Registration document
First half report
